Revenue increases expected and is great to hear, however the bottom line result has to improve markedly. To date that is in no way reflected in any increased revenue. Sounds like any improvement on that front is a while away.
Whilst revenue has increased, one suspects the expectation was for a better one than announced given all the fanfare prior to the last CR.
Market reaction is hardly in the positive affirmative. Hopefully that will change once or if JAT actually makes money. When is as yet unknown.
- Forums
- ASX - By Stock
- JAT
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
JAT
jatcorp limited
Add to My Watchlist
1.28%
!
38.5¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $32.05M |
Open | High | Low | Value | Volume |
38.5¢ | 39.0¢ | 38.0¢ | $23.49K | 60.62K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8031 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 204384 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8031 | 0.385 |
2 | 24714 | 0.380 |
1 | 8000 | 0.370 |
1 | 13880 | 0.360 |
2 | 59992 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 204384 | 1 |
0.420 | 10000 | 1 |
0.440 | 1000 | 1 |
0.450 | 7839 | 2 |
0.460 | 500000 | 1 |
Last trade - 14.29pm 04/07/2025 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online